Eurofins Scientific Nante (ERFSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ERFSF | MEDP | SOLV | ||
| Company | Eurofins Scientific Nante | Medpace Holdings Inc | Solventum Corporation | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | ||
| Open | 74.4000 | 562.47 | 80.80 | ||
| High | 74.7200 | 569.66 | 81.68 | ||
| Low | 72.5501 | 561.20 | 80.54 | ||
| Latest | 74.2100 | 568.36 | 81.59 | ||
| Change | -0.5100 | +8.15 | +0.91 | ||
| % Change | -0.68% | +1.45% | +1.13% | ||
| Volume | 600 | 378,400 | 3,276,400 | ||
| 20-Day Average Volume | 2,190 | 290,125 | 1,245,675 | ||
| Previous Close | 74.7200 | 560.21 | 80.68 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 69.2018 | 572.19 | 83.24 | ||
| 20-Day Raw Stochastic | 94.76% | 39.25% | 21.68% | ||
| 20-Day Relative Strength | 56.74 | 50.96 | 56.30 | ||
| Weighted Alpha | +40.02 | +49.86 | +23.30 | ||
| Today's Opinion | 40% Buy | 40% Buy | 88% Buy | ||
| Previous Opinion | 32% Buy | 56% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Sell | 88% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.13% since 12/12/25 | +1.87% since 12/12/25 | -1.68% since 12/12/25 | ||
| Low | 66.9600 on 12/15/25 | 544.24 on 12/16/25 | 79.76 on 12/17/25 | ||
| High | 74.7200 on 12/19/25 | 572.44 on 12/18/25 | 84.00 on 12/15/25 | ||
| 1-Month | |||||
| %Chg | +13.30% since 11/19/25 | -4.02% since 11/19/25 | +5.54% since 11/19/25 | ||
| Low | 64.9780 on 12/09/25 | 530.96 on 12/04/25 | 78.00 on 11/20/25 | ||
| High | 74.7200 on 12/19/25 | 626.26 on 11/25/25 | 88.20 on 12/02/25 | ||
| 3-Month | |||||
| %Chg | +0.42% since 09/19/25 | +13.99% since 09/19/25 | +10.68% since 09/19/25 | ||
| Low | 64.9780 on 12/09/25 | 484.00 on 09/25/25 | 66.11 on 11/06/25 | ||
| High | 76.3700 on 10/02/25 | 626.26 on 11/25/25 | 88.20 on 12/02/25 | ||
| 6-Month | |||||
| %Chg | +4.72% since 06/18/25 | +87.77% since 06/18/25 | +12.34% since 06/18/25 | ||
| Low | 64.9780 on 12/09/25 | 301.90 on 06/20/25 | 66.11 on 11/06/25 | ||
| High | 83.0200 on 07/25/25 | 626.26 on 11/25/25 | 88.20 on 12/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,321,120 | 16,009,559 | 14,151,620 | ||
| Shares Outstanding, K | 192,981 | 28,168 | 173,448 | ||
| Annual Sales | 7,521,680,000 | 2,109,050,000 | 8,254,000,000 | ||
| Annual Net Income | 439,770,000 | 404,390,000 | 478,000,000 | ||
| Last Quarter Sales | N/A | 659,900,000 | 2,096,000,000 | ||
| Last Quarter Net Income | N/A | 111,140,000 | 1,266,000,000 | ||
| 60-Month Beta | 0.63 | 1.43 | 0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.86 on 10/22/25 | 1.50 on 11/06/25 | ||
| Latest Earnings Date | 01/01/70 | 02/09/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 39.75 | 13.74 | ||